Psyence Biomedical (PBMWW) Competitors

$0.01

0.00 (0.00%)

(As of 09/18/2024 ET)

PBMWW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BCAX, and BFRIW

Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Bicara Therapeutics (BCAX), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

Psyence Biomedical vs.

180 Life Sciences (NASDAQ:ATNFW) and Psyence Biomedical (NASDAQ:PBMWW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Psyence Biomedical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, 180 Life Sciences had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 1.87 beat 180 Life Sciences' score of 1.44 indicating that Psyence Biomedical is being referred to more favorably in the news media.
Company Overall Sentiment
180 Life Sciences Positive
Psyence Biomedical Very Positive
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
Psyence Biomedical N/A N/A N/A N/A N/A
: 180 Life Sciences and Psyence Biomedical both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
Psyence Biomedical N/A N/A
: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
Psyence Biomedical N/A N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Psyence Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
180 Life Sciences	Positive
Psyence Biomedical	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Psyence Biomedical	N/A	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
Psyence Biomedical	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Psyence Biomedical	N/A	N/A	N/A

Summary

180 Life Sciences and Psyence Biomedical tied by winning 1 of the 2 factors compared between the two stocks.

Ad Paradigm Press

Kamala’s Dirty Election Move… Revealed

According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…

Click here now and learn how to prepare.

Get Psyence Biomedical News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PBMWW vs. The Competition

Export to Excel

Metric	Psyence Biomedical	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	$7.51B	$1.98B	$8.27B
Dividend Yield	N/A	4.33%	2.63%	4.08%
P/E Ratio	N/A	19.12	26.57	18.58
Price / Sales	N/A	259.07	570.20	74.13
Price / Cash	N/A	37.10	40.22	31.89
Price / Book	N/A	5.89	2.19	4.54
Net Income	N/A	$150.42M	$170.80M	$224.30M
7 Day Performance	N/A	4.79%	1.59%	5.57%
1 Month Performance	N/A	13.81%	1.50%	8.86%
1 Year Performance	N/A	22.21%	8.77%	12.05%

Psyence Biomedical Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-45.1%	$0.00	N/A	0.00	7	Positive News Gap Up
LBPSW 4D pharma	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	$522,000.00	0.00	N/A
AEHAW Aesther Healthcare Acquisition	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	N/A	0.00	2	Gap Up
AIMDW Ainos	0 of 5 stars 0.00 / 5 stars	$0.05 flat	N/A	-66.9%	$0.00	$65,122.00	0.00	40	Positive News
ALVOW Alvotech	0 of 5 stars 0.00 / 5 stars	$2.55 flat	N/A	N/A	$0.00	$306.77M	0.00	4	Positive News
ALVO Alvotech	2.8154 of 5 stars 2.82 / 5 stars	$10.81 +0.1%	$14.00 +29.5%	+20.5%	$0.00	$93.38M	-5.20	1,026	Positive News
ACABW Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	-14.4%	$0.00	N/A	0.00	4	Positive News Gap Down
ACABU Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$10.99 flat	N/A	N/A	$0.00	N/A	0.00	4	Positive News
BCAX Bicara Therapeutics	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	32	Insider Buying News Coverage High Trading Volume
BFRIW Biofrontera	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	-32.3%	$0.00	$35.24M	0.00	70